Literature DB >> 14527050

Inadequate follow-up for abnormal Pap smears in an urban population.

Neeraja B Peterson1, Jini Han, Karen M Freund.   

Abstract

PURPOSE: To determine the factors associated with inadequate follow-up for abnormal Pap smears among a cohort of Boston women from urban academic clinics.
METHODS: Subjects were women > 18 years with abnormal cervical cytology between February 1999 and April 2000. Inadequate follow-up was defined as lack of subsequent cervical cytology or pathology specimen within four months of the initial abnormal specimen for high-grade lesions or within 7 months for low-grade lesions.
RESULTS: Of the 423 subjects, the mean age was 33 years. Sixty percent were black, 23% Hispanic, 15% white, 2% Asian. The population was largely uninsured or publically insured. The overall inadequate follow-up rate was 38%. In bivariate analysis, age was a significant risk factor; 46% of women ages 18-29 had inadequate follow-up (p < 0.01). In multivariate analysis, women aged 18-29 years were more likely than women 50 years and older to have inadequate follow-up (OR 2.7, 95% CI 1.1-6.4), as were women with Medicaid insurance compared with private insurance (OR 1.9, 95% CI 1.01-3.5). After 12 months, 26% of women with abnormal Pap smears still had not received follow-up.
CONCLUSIONS: In a predominantly urban minority population, the overall rate of inadequate follow-up for abnormal Pap smears was high at 38%. Programs to address follow-up of abnormal cervical cytology should focus on minority populations, especially younger and all low-income women.

Entities:  

Mesh:

Year:  2003        PMID: 14527050      PMCID: PMC2594474     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  15 in total

1.  Improving follow-up after an abnormal Pap smear: a randomized controlled trial.

Authors:  E D Paskett; E White; W B Carter; J Chu
Journal:  Prev Med       Date:  1990-11       Impact factor: 4.018

2.  Effectiveness of a case management protocol in improving follow-up and referral of Papanicolaou smears indicating cervical intraepithelial neoplasia.

Authors:  L E Frisch
Journal:  J Am Coll Health       Date:  1986-11

3.  Investigation of non-responders at a cervical cancer screening clinic in Manchester.

Authors:  V Nathoo
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

4.  Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).

Authors:  V B Benard; N C Lee; M Piper; L Richardson
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

5.  Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center.

Authors:  M D McKee; J Lurio; P Marantz; W Burton; M Mulvihill
Journal:  Arch Fam Med       Date:  1999 Mar-Apr

6.  Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia.

Authors:  R Michielutte; R A Diseker; L D Young; W J May
Journal:  Prev Med       Date:  1985-03       Impact factor: 4.018

7.  Compliance with referrals from a cancer-screening project.

Authors:  D S Lane
Journal:  J Fam Pract       Date:  1983-11       Impact factor: 0.493

8.  Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model.

Authors:  E D Paskett; W B Carter; J Chu; E White
Journal:  Med Care       Date:  1990-07       Impact factor: 2.983

9.  Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.

Authors:  A C Marcus; L A Crane; C P Kaplan; A E Reading; E Savage; J Gunning; G Bernstein; J S Berek
Journal:  Med Care       Date:  1992-03       Impact factor: 2.983

10.  Compliance with therapy for cervical dysplasia among women of low socioeconomic status.

Authors:  T W Laedtke; M Dignan
Journal:  South Med J       Date:  1992-01       Impact factor: 0.954

View more
  23 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

2.  Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication.

Authors:  Melissa A Simon; Ludmila Cofta-Woerpel; Veenu Randhawa; Priya John; Gregory Makoul; Bonnie Spring
Journal:  Patient Educ Couns       Date:  2010-01-08

3.  Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.

Authors:  Faith E Fletcher; Meredith Buchberg; Leslie R Schover; Karen Basen-Engquist; Mirjam-Colette Kempf; Roberto C Arduino; Damon J Vidrine
Journal:  AIDS Care       Date:  2014-03-18

4.  The impact of insurance coverage during insurance reform on diagnostic resolution of cancer screening abnormalities.

Authors:  Alok Kapoor; Tracy A Battaglia; Alexis P Isabelle; Amresh D Hanchate; Richard L Kalish; Sharon Bak; Rebecca G Mishuris; Swati M Shroff; Karen M Freund
Journal:  J Health Care Poor Underserved       Date:  2014-02

5.  National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures.

Authors:  Karen M Freund; Tracy A Battaglia; Elizabeth Calhoun; Donald J Dudley; Kevin Fiscella; Electra Paskett; Peter C Raich; Richard G Roetzheim
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

6.  Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Authors:  Alison G Abraham; Gypsyamber D'Souza; Yuezhou Jing; Stephen J Gange; Timothy R Sterling; Michael J Silverberg; Michael S Saag; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Richard D Moore; Marina B Klein; Mari M Kitahata; Gregory D Kirk; Robert S Hogg; Nancy A Hessol; James J Goedert; M John Gill; Kelly A Gebo; Joseph J Eron; Eric A Engels; Robert Dubrow; Heidi M Crane; John T Brooks; Ronald J Bosch; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

7.  A theory-based approach to understanding follow-up of abnormal Pap tests.

Authors:  Carmen Radecki Breitkopf; Heidi C Pearson
Journal:  J Health Psychol       Date:  2009-04

8.  ACCISS study rationale and design: activating collaborative cancer information service support for cervical cancer screening.

Authors:  Ludmila Cofta-Woerpel; Veenu Randhawa; H Gene McFadden; Angela Fought; Emily Bullard; Bonnie Spring
Journal:  BMC Public Health       Date:  2009-12-02       Impact factor: 3.295

9.  Factors Associated With Adherence to Follow-up Colposcopy.

Authors:  Laura J Fish; Patricia G Moorman; Lashawn Wordlaw-Stintson; Adriana Vidal; Jennifer S Smith; Cathrine Hoyo
Journal:  Am J Health Educ       Date:  2013

10.  Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population.

Authors:  Lena B Palmer; Michael D Kappelman; Robert S Sandler; Paul H Hayashi
Journal:  J Clin Gastroenterol       Date:  2013-09       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.